2022
DOI: 10.3332/ecancer.2022.1362
|View full text |Cite
|
Sign up to set email alerts
|

The relationship between tumour infiltrating lymphocytes, Epstein–Barr virus and Helicobacter pylori infection in gastric cancer

Abstract: Objective: Epstein-Barr virus (EBV) and Helicobacter pylori (HP) infections have been extensively recognised as gastric cancer (GC) triggers, and recent publications suggest they could behave as predictive markers for immune-modulating therapies. Tumourinfiltrating lymphocytes (TILs) have also been identified as a predictive biomarker for immunotherapy in different malignancies. This study aimed to investigate the association between EBV and HP infection with TIL levels in GC.Methods: TIL evaluation in haemato… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 23 publications
(41 reference statements)
0
0
0
Order By: Relevance
“…Gastric cancer (GC) is one of the most common cancers throughout the world and the second most frequent in Peruvian males, and carries a poor prognosis[ 1 - 3 ]. The pathological features of GC can define tumor behavior and prognosis[ 4 ]. Helicobacter pylori ( H. pylori ) infection, which is highly prevalent in Peru, is an accepted trigger of GC and has recently been suggested to predict a lower effect of immunotherapy with checkpoint immune inhibitors[ 5 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Gastric cancer (GC) is one of the most common cancers throughout the world and the second most frequent in Peruvian males, and carries a poor prognosis[ 1 - 3 ]. The pathological features of GC can define tumor behavior and prognosis[ 4 ]. Helicobacter pylori ( H. pylori ) infection, which is highly prevalent in Peru, is an accepted trigger of GC and has recently been suggested to predict a lower effect of immunotherapy with checkpoint immune inhibitors[ 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…High levels of tumor-infiltrating lymphocytes (TILs) have been associated with longer survival and greater response to checkpoint inhibitors in different malignancies[ 13 , 14 ]. Information on the type, density and location of TIL subpopulations has been associated with tumor features, such as Epstein-Barr-Virus infection[ 4 ] and survival in gastrointestinal malignancies[ 15 , 16 ], and predicts response to checkpoint inhibitors in advanced GC[ 11 , 17 - 19 ]. Despite the relevance of H. pylori infection, dMMR and HER2 status in GC, few studies have evaluated their association with TIL levels in resected non-metastatic tumors.…”
Section: Introductionmentioning
confidence: 99%